ETF Holdings Breakdown of ILMN

Stock Name	Illumina Inc
Ticker	ILMN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4523271090
LEI	SQ95QG8SR5Q56LSNF682

ILMN institutional holdings

The following institutional investment holdings of ILMN have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share
2025-11-27	IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc))	246,948	USD 32,056,320	129.81
2025-11-27	IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist))	246,948	USD 32,056,320	129.81
2025-11-27	IE00BKBF6H24 (iShares Core MSCI World UCITS ETF)	246,948	USD 32,056,320	129.81
2025-11-27	IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist))	246,948	USD 32,056,320	129.81
2025-11-27	IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist))	32,926	USD 4,274,124	129.81
2025-11-24	IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc))	41,229 0.2%	USD 5,193,205 1.9%	125.96
2025-11-27	IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist))	50,862	USD 6,602,396	129.81
2025-11-27	IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc))	50,862	USD 6,602,396	129.81
2025-11-27	IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc))	43,498 200.0%	USD 5,646,475 200.0%	129.81
2025-11-27	IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist))	43,498 200.0%	USD 5,646,475 200.0%	129.81
2025-11-27	IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist))	14,915	USD 1,936,116	129.81
2025-11-27	IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP)	3,659	USD 474,975	129.81
2025-11-27	IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist))	12,297	USD 1,596,274	129.81
2025-11-27	IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF)	12,297	USD 1,596,274	129.81
2025-11-27	IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc))	7,653	USD 993,436	129.81
2025-11-27	IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc))	13,371	USD 1,735,690	129.81
2025-11-27	IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD)	3,148	USD 408,642	129.81
2025-11-27	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	168,759	USD 21,906,606	129.81
2025-11-27	IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc))	61,591 200.0%	USD 7,995,128 200.0%	129.81
2025-11-27	IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF)	3,165	USD 410,849	129.81
2025-11-27	IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc))	3,165	USD 410,849	129.81
2025-11-27	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	103,463	USD 13,430,532	129.81
2025-11-27	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	103,463	USD 13,430,532	129.81
2025-11-27	IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist))	1,258	USD 163,301	129.81
2025-11-27	IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc))	1,258	USD 163,301	129.81
2025-11-27	IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc))	3,958	USD 513,788	129.81
2025-11-27	IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc))	8,082	USD 1,049,124	129.81
2025-11-27	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	1,425	USD 184,979	129.81
2025-11-27	IE00BD0B9B76 (iShares Refinitiv Inclusion and Diversity UCITS ETF USD (Acc))	4,435	USD 575,707	129.81
2025-11-27	IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc))	1,054	USD 136,820	129.81
2025-11-27	IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist))	23	USD 2,986	129.83
2025-11-27	IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc))	23	USD 2,986	129.83
2025-11-27	IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist))	20	USD 2,596	129.80
2025-11-27	IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc))	20	USD 2,596	129.80
2025-11-27	IE00B6R52259 (iShares MSCI ACWI UCITS ETF)	41,418	USD 5,376,471	129.81
2025-11-27	IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc))	50,862	USD 6,602,396	129.81
2025-11-27	IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP)	3,659	USD 474,975	129.81
2025-11-27	IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc))	10,082	USD 1,128,763 0.0%	111.96
2025-11-27	IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc))	985	USD 96,500 -0.2%	97.97
Total =	1,890,175	USD 244,993,543

News associated with ILMN

Fidelity MSCI Health Care Index ETF -- Insider Buying Index Registering 19.3%: A look at the weighted underlying holdings of the Fidelity MSCI Health Care Index ETF (Symbol: FHLC) shows an impressive 19.3% of holdings on a weighted basis have experienced insider buying within the past six months. Illumina Inc (Symbol: ILMN), which makes up 0.27% of the F - 2025-09-09 10:54:08
Illumina, Inc. (NASDAQ:ILMN) Given Consensus Rating of “Hold” by Brokerages: Shares of Illumina, Inc. (NASDAQ:ILMN – Get Free Report) have received an average rating of “Hold” from the nineteen analysts that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and six have assigned a buy recommendation to the company. The […] - 2025-09-02 02:18:58
Citigroup Inc. Has $11.96 Million Stock Position in Illumina, Inc. (NASDAQ:ILMN): Citigroup Inc. increased its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 13.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,764 shares of the life sciences company’s stock after buying an additional 17,985 shares during the period. […] - 2025-08-15 07:18:47
Maryland State Retirement & Pension System Has $591,000 Stock Holdings in Illumina, Inc. (NASDAQ:ILMN): Maryland State Retirement & Pension System trimmed its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 15.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,446 shares of the life sciences company’s stock after selling 1,371 shares during the period. Maryland […] - 2025-08-14 06:01:03
PNC Financial Services Group Inc. Sells 6,373 Shares of Illumina, Inc. (NASDAQ:ILMN): PNC Financial Services Group Inc. lessened its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 32.2% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,400 shares of the life sciences company’s stock after selling 6,373 shares during the quarter. PNC […] - 2025-08-11 06:16:54
Cetera Investment Advisers Has $2.09 Million Stake in Illumina, Inc. (NASDAQ:ILMN): Cetera Investment Advisers increased its position in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 13.7% during the first quarter, Holdings Channel.com reports. The institutional investor owned 26,280 shares of the life sciences company’s stock after purchasing an additional 3,173 shares during the period. Cetera Investment Advisers’ holdings in Illumina were worth $2,085,000 as […] - 2025-08-08 05:22:48
Illumina (NASDAQ:ILMN) Cut to Hold at Wall Street Zen: Wall Street Zen downgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a buy rating to a hold rating in a research report released on Saturday morning. ILMN has been the topic of several other research reports. Guggenheim decreased their price objective on Illumina from $122.00 to $114.00 and set a “buy” rating on the […] - 2025-08-05 03:00:55
Canaccord Genuity Group Boosts Illumina (NASDAQ:ILMN) Price Target to $105.00: Illumina (NASDAQ:ILMN – Free Report) had its target price upped by Canaccord Genuity Group from $99.00 to $105.00 in a report released on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the life sciences company’s stock. ILMN has been the subject of a number of other research reports. Morgan Stanley decreased […] - 2025-08-04 04:34:54
Head to Head Analysis: Illumina (NASDAQ:ILMN) & Opus Genetics (NASDAQ:IRD): Illumina (NASDAQ:ILMN – Get Free Report) and Opus Genetics (NASDAQ:IRD – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Earnings & Valuation This table compares Illumina and Opus […] - 2025-07-30 03:08:44
Victory Capital Management Inc. Decreases Stake in Illumina, Inc. (NASDAQ:ILMN): Victory Capital Management Inc. decreased its stake in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 1.0% during the first quarter, Holdings Channel reports. The firm owned 53,039 shares of the life sciences company’s stock after selling 511 shares during the quarter. Victory Capital Management Inc.’s holdings in Illumina were worth $4,208,000 as of […] - 2025-07-28 05:02:49
ILMN Crosses Above Average Analyst Target: In recent trading, shares of Illumina Inc (Symbol: ILMN) have crossed above the average analyst 12-month target price of $106.83, changing hands for $107.64/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua - 2025-07-25 09:07:06
Signaturefd LLC Has $128,000 Position in Illumina, Inc. (NASDAQ:ILMN): Signaturefd LLC cut its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 14.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,608 shares of the life sciences company’s stock after selling 272 shares during the period. Signaturefd LLC’s holdings […] - 2025-07-21 05:09:35
Illumina, Inc. (NASDAQ:ILMN) Receives $125.11 Consensus Price Target from Analysts: Shares of Illumina, Inc. (NASDAQ:ILMN – Get Free Report) have been assigned an average rating of “Hold” from the twenty brokerages that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation, eight have issued a buy recommendation and one has […] - 2025-07-17 03:12:59
Xponance Inc. Raises Holdings in Illumina, Inc. (NASDAQ:ILMN): Xponance Inc. lifted its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 1.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 26,762 shares of the life sciences company’s stock after buying an additional 264 shares during the […] - 2025-07-15 07:02:52
Allworth Financial LP Has $456,000 Stock Position in Illumina, Inc. (NASDAQ:ILMN): Allworth Financial LP decreased its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 17.6% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,877 shares of the life sciences company’s stock after selling 1,255 shares during the quarter. Allworth Financial LP’s holdings in Illumina […] - 2025-07-15 06:25:07
Illumina (NASDAQ:ILMN) Cut to “Sector Perform” at Scotiabank: Scotiabank downgraded shares of Illumina (NASDAQ:ILMN – Free Report) from a sector outperform rating to a sector perform rating in a report issued on Friday morning, Marketbeat.com reports. They currently have $125.00 price objective on the life sciences company’s stock. ILMN has been the topic of several other research reports. JPMorgan Chase & Co. lowered […] - 2025-07-14 03:46:45
Principal Financial Group Inc. Has $28.92 Million Position in Illumina, Inc. (NASDAQ:ILMN): Principal Financial Group Inc. lessened its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 23.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 364,472 shares of the life sciences company’s stock after selling 114,747 shares during the quarter. Principal Financial Group […] - 2025-07-09 05:44:51
GAMMA Investing LLC Sells 2,273 Shares of Illumina, Inc. (NASDAQ:ILMN): GAMMA Investing LLC lowered its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 73.4% in the 1st quarter, HoldingsChannel.com reports. The firm owned 823 shares of the life sciences company’s stock after selling 2,273 shares during the period. GAMMA Investing LLC’s holdings in Illumina were worth $65,000 at the end of the most recent […] - 2025-07-09 04:24:54
Sequoia Financial Advisors LLC Has $325,000 Stock Holdings in Illumina, Inc. (NASDAQ:ILMN): Sequoia Financial Advisors LLC decreased its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 28.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,091 shares of the life sciences company’s stock after selling 1,642 shares during […] - 2025-07-04 04:42:48
Mirae Asset Global Investments Co. Ltd. Reduces Stock Position in Illumina, Inc. (NASDAQ:ILMN): Mirae Asset Global Investments Co. Ltd. lowered its stake in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 15.6% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 40,305 shares of the life sciences company’s stock after selling 7,441 shares during the […] - 2025-07-03 05:23:10
4,471 Shares in Illumina, Inc. (NASDAQ:ILMN) Acquired by Diversified Trust Co: Diversified Trust Co purchased a new stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 4,471 shares of the life sciences company’s stock, valued at approximately $355,000. Several other institutional investors also recently made changes to their […] - 2025-07-01 06:37:01
Illumina Sees Unusually Large Options Volume (NASDAQ:ILMN): Illumina, Inc. (NASDAQ:ILMN – Get Free Report) saw some unusual options trading activity on Thursday. Traders purchased 10,974 call options on the company. This represents an increase of 212% compared to the typical volume of 3,514 call options. Illumina Trading Up 1.0% Shares of NASDAQ ILMN opened at $94.16 on Friday. Illumina has a 1-year […] - 2025-06-27 02:38:51
Kentucky Retirement Systems Insurance Trust Fund Buys New Stake in Illumina, Inc. (NASDAQ:ILMN): Kentucky Retirement Systems Insurance Trust Fund purchased a new position in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) in the first quarter, Holdings Channel.com reports. The firm purchased 4,632 shares of the life sciences company’s stock, valued at approximately $368,000. Other institutional investors also recently bought and sold shares of the company. Capital World […] - 2025-06-26 05:03:05
10,875 Shares in Illumina, Inc. (NASDAQ:ILMN) Purchased by Kentucky Retirement Systems: Kentucky Retirement Systems bought a new position in Illumina, Inc. (NASDAQ:ILMN – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,875 shares of the life sciences company’s stock, valued at approximately $863,000. Several other large investors also recently modified […] - 2025-06-25 06:12:47
Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by State of Alaska Department of Revenue: State of Alaska Department of Revenue raised its stake in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 2.5% in the 1st quarter, HoldingsChannel.com reports. The firm owned 18,527 shares of the life sciences company’s stock after purchasing an additional 445 shares during the quarter. State of Alaska Department of Revenue’s holdings in Illumina […] - 2025-06-25 05:35:03
Avior Wealth Management LLC Has $194,000 Stock Position in Illumina, Inc. (NASDAQ:ILMN): Avior Wealth Management LLC trimmed its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 29.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,442 shares of the life sciences company’s stock after selling 1,012 shares during the period. Avior Wealth Management […] - 2025-06-24 05:32:59
Illumina, Inc. (NASDAQ:ILMN) Given Consensus Rating of “Hold” by Analysts: Illumina, Inc. (NASDAQ:ILMN – Get Free Report) has earned an average recommendation of “Hold” from the nineteen brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation, eight have assigned a buy recommendation and one has given a strong […] - 2025-06-19 03:04:49
Mn Services Vermogensbeheer B.V. Reduces Stock Position in Illumina, Inc. (NASDAQ:ILMN): Mn Services Vermogensbeheer B.V. lessened its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 7.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 57,400 shares of the life sciences company’s stock after selling 4,500 shares during the quarter. Mn Services Vermogensbeheer B.V.’s […] - 2025-06-18 05:32:50
Yousif Capital Management LLC Sells 1,354 Shares of Illumina, Inc. (NASDAQ:ILMN): Yousif Capital Management LLC lessened its stake in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 2.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,586 shares of the life sciences company’s stock after selling 1,354 shares during the quarter. Yousif […] - 2025-06-13 06:26:57
Investors Buy Large Volume of Illumina Call Options (NASDAQ:ILMN): Illumina, Inc. (NASDAQ:ILMN – Get Free Report) saw some unusual options trading activity on Tuesday. Traders bought 6,429 call options on the stock. This is an increase of 67% compared to the typical daily volume of 3,845 call options. Insider Buying and Selling at Illumina In other news, CFO Ankur Dhingra acquired 6,100 shares of […] - 2025-06-11 02:28:42

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.